Cargando…

Mild cognitive impairment and its management in older people

Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshkoor, Sima Ataollahi, Hamid, Tengku Aizan, Mun, Chan Yoke, Ng, Chee Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401355/
https://www.ncbi.nlm.nih.gov/pubmed/25914527
http://dx.doi.org/10.2147/CIA.S73922
_version_ 1782367137512292352
author Eshkoor, Sima Ataollahi
Hamid, Tengku Aizan
Mun, Chan Yoke
Ng, Chee Kyun
author_facet Eshkoor, Sima Ataollahi
Hamid, Tengku Aizan
Mun, Chan Yoke
Ng, Chee Kyun
author_sort Eshkoor, Sima Ataollahi
collection PubMed
description Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can act as a transitional level of evolving dementia with a range of conversion of 10%–15% per year. Thus, it is crucial to protect older people against MCI and developing dementia. The preventive interventions and appropriate treatments should improve cognitive performance, and retard or prevent progressive deficits. The avoidance of toxins, reduction of stress, prevention of somatic diseases, implementation of mental and physical exercises, as well as the use of dietary compounds like antioxidants and supplements can be protective against MCI. The modification of risk factors such as stopping smoking, as well as the treatment of deficiency in vitamins and hormones by correcting behaviors and lifestyle, can prevent cognitive decline in the elderly. The progressive increase in the growth rate of the elderly population can enhance the rate of MCI all over the world. There is no exact cure for MCI and dementia; therefore, further studies are needed in the future to determine causes of MCI and risk factors of progression from MCI to dementia. This will help to find better ways for prevention and treatment of cognitive impairment worldwide.
format Online
Article
Text
id pubmed-4401355
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44013552015-04-24 Mild cognitive impairment and its management in older people Eshkoor, Sima Ataollahi Hamid, Tengku Aizan Mun, Chan Yoke Ng, Chee Kyun Clin Interv Aging Review Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can act as a transitional level of evolving dementia with a range of conversion of 10%–15% per year. Thus, it is crucial to protect older people against MCI and developing dementia. The preventive interventions and appropriate treatments should improve cognitive performance, and retard or prevent progressive deficits. The avoidance of toxins, reduction of stress, prevention of somatic diseases, implementation of mental and physical exercises, as well as the use of dietary compounds like antioxidants and supplements can be protective against MCI. The modification of risk factors such as stopping smoking, as well as the treatment of deficiency in vitamins and hormones by correcting behaviors and lifestyle, can prevent cognitive decline in the elderly. The progressive increase in the growth rate of the elderly population can enhance the rate of MCI all over the world. There is no exact cure for MCI and dementia; therefore, further studies are needed in the future to determine causes of MCI and risk factors of progression from MCI to dementia. This will help to find better ways for prevention and treatment of cognitive impairment worldwide. Dove Medical Press 2015-04-10 /pmc/articles/PMC4401355/ /pubmed/25914527 http://dx.doi.org/10.2147/CIA.S73922 Text en © 2015 Eshkoor et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Eshkoor, Sima Ataollahi
Hamid, Tengku Aizan
Mun, Chan Yoke
Ng, Chee Kyun
Mild cognitive impairment and its management in older people
title Mild cognitive impairment and its management in older people
title_full Mild cognitive impairment and its management in older people
title_fullStr Mild cognitive impairment and its management in older people
title_full_unstemmed Mild cognitive impairment and its management in older people
title_short Mild cognitive impairment and its management in older people
title_sort mild cognitive impairment and its management in older people
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401355/
https://www.ncbi.nlm.nih.gov/pubmed/25914527
http://dx.doi.org/10.2147/CIA.S73922
work_keys_str_mv AT eshkoorsimaataollahi mildcognitiveimpairmentanditsmanagementinolderpeople
AT hamidtengkuaizan mildcognitiveimpairmentanditsmanagementinolderpeople
AT munchanyoke mildcognitiveimpairmentanditsmanagementinolderpeople
AT ngcheekyun mildcognitiveimpairmentanditsmanagementinolderpeople